BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9
• 10
• 11
• 12
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  Legend Biotech Corporation Announces Proposed Public Offering - June 17, 2026

  June 18, 2026

   · 

  4 min read
• Press Releases

  Satellos Bioscience Announces Results of Annual Meeting of Shareholders

  June 18, 2026

   · 

  5 min read
• Press Releases

  The Ottawa Hospital’s Biotherapeutics Manufacturing Centre (BMC) makes breakthroughs break through as Boreal Biomanufacturing

  CDMO continues on path to commercial growth, expansion

  June 18, 2026

   · 

  1 min read
• Press Releases

  LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide

  June 18, 2026

   · 

  6 min read
• Press Releases

  Cenna Biosciences Receives FDA Clearance to Begin Phase 1a/1b Clinical Trial of 8M2D, a First-in-Class Peptide Designed to Stop the Production of Amyloid in Alzheimer’s Disease

  June 18, 2026

   · 

  4 min read
• Press Releases

  Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.

  June 18, 2026

   · 

  8 min read
• Press Releases

  LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody

  June 18, 2026

   · 

  3 min read
• Press Releases

  Kardigan Announces Pricing of Upsized Initial Public Offering

  June 18, 2026

   · 

  4 min read
• Press Releases

  Paradigm Clinical Research Opens Psychedelic Research Suite in Redding, California

  New specialized treatment site expands Paradigm’s capabilities for psychiatric clinical trials and studies evaluating investigational psychedelic-assisted therapies

  June 18, 2026

   · 

  1 min read
• Press Releases

  Legend Biotech Corporation Announces Pricing of Public Offering - June 17, 2026

  June 18, 2026

   · 

  4 min read